ClinicalTrials.gg
Drug

Sulfur Hexafluoride clinical trials

Also written Lumason and SonoVue.

Includes 14 studies of Contrast agent BR1.

studies test it
52
open now
13
in phase 3
17
first study started
2008

How each study uses Sulfur Hexafluoride is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Sulfur Hexafluoride studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
10 Oct 2014 · LUMASON · NDA 203684 (FDA, Drugs@FDA)
European Union
26 Mar 2001 · SonoVue · EMEA/H/C/000303 (EMA; as contrast agent BR1)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Sulfur hexafluoride lipid-type A microspheres
11
Sulfur Hexafluoride Lipid Microspheres
6
Sulfur Hexafluoride
4
SF6 Lipid Microspheres
4
Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON]
3

Brand

Lumason
28
SonoVue
8

Studies by the year they started

51 studies that test it; most in 2020 (7); 1 more planned to start later

Studies that test Sulfur Hexafluoride, by start year
YearStudies
20081
20092
20101
20112
20121
20142
20153
20163
20176
20183
20195
20207
20212
20223
20231
20245
20251
20263

By phase

A phase 1/2 study counts in both.

Early Phase 1
5
Phase 1
7
Phase 2
11
Phase 3
17
Phase 4
7
No phase
8

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 8 · Other 44

Bracco Diagnostics, Inc (7) · Children's Hospital of Philadelphia (6) · Mayo Clinic (3) · David Mooney (2) · Indiana University (2) · UNC Lineberger Comprehensive Cancer Center (2) · Milton S. Hershey Medical Center (2) · Boston Children's Hospital (2)

Often tested with

Tested in the same studies.

Perflutren (4) · FS 069 (1) · Iodixanol (1) · Sonazoid (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 8, 1 in phase 3

Studies that test Sulfur Hexafluoride, phase 3 first.

Studies

Open first, then newest update. How each study uses Sulfur Hexafluoride is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 52

See all 52 studies that test Sulfur Hexafluoride →

Given beside what is tested · 8 — Sulfur Hexafluoride is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with Sulfur Hexafluoride

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call Sulfur Hexafluoride · ClinicalTrials.gg INT008258

  • MeSH (NLM) D013459Sulfur HexafluorideConfirmed NLM, Wikidata
  • UNII (FDA) WS7LR3I1D6SULFUR HEXAFLUORIDEConfirmed FDA, NLM, Wikidata
  • RxNorm 1599276Confirmed FDA, Wikidata
  • Wikidata Q279055sulfur hexafluorideConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C84187Sulfur HexafluorideOne source FDA
  • DrugBank DB11104One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.